FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 107 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $192,466 | -95.9% | 31,043 | -93.7% | 0.00% | -100.0% |
| Q1 2024 | $4,688,650 | +45.9% | 496,679 | +4.3% | 0.00% | 0.0% |
| Q4 2023 | $3,214,391 | +8945.4% | 476,206 | +3719.1% | 0.00% | – |
| Q1 2023 | $35,536 | -62.4% | 12,469 | -3.9% | 0.00% | – |
| Q4 2022 | $94,479 | +5.0% | 12,978 | +15.5% | 0.00% | – |
| Q3 2022 | $90,000 | +63.6% | 11,241 | +1.3% | 0.00% | – |
| Q2 2022 | $55,000 | -99.0% | 11,100 | -95.0% | 0.00% | -100.0% |
| Q1 2022 | $5,284,000 | +178.0% | 223,460 | +107.9% | 0.00% | – |
| Q4 2021 | $1,901,000 | -88.7% | 107,467 | -82.0% | 0.00% | -100.0% |
| Q3 2021 | $16,815,000 | – | 596,057 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $70,091,000 | 17.54% |
| TRV GP IV, LLC | 2,343,154 | $41,450,000 | 11.92% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $3,538,000 | 1.49% |
| HighVista Strategies LLC | 89,963 | $1,591,000 | 1.27% |
| Logos Global Management LP | 685,000 | $12,118,000 | 1.25% |
| Monashee Investment Management LLC | 273,045 | $4,830,000 | 1.19% |
| RTW INVESTMENTS, LP | 3,866,872 | $68,405,000 | 1.00% |
| Parkman Healthcare Partners LLC | 250,106 | $4,424,000 | 0.98% |
| Deep Track Capital, LP | 750,000 | $13,268,000 | 0.94% |
| Darwin Global Management, Ltd. | 317,428 | $5,615,000 | 0.86% |